Becky Lau

Chinese University of Hong Kong

Papers

1

Total Citations

2

H-Index

1

About

Dr. Becky Lau is a pioneering urologic surgeon and researcher whose work centers on the intersection of minimally invasive surgical techniques and oncology, with a particular focus on prostate cancer management. Her major contributions lie in evaluating novel interventions that aim to improve both oncologic control and quality of life for patients. In her highly cited 2025 study, "Robotic Waterjet Resection for Men With Prostate Cancer Suffering From Lower Urinary Tract Symptoms," Dr. Lau investigates the impact of Aquablation—a robotic waterjet therapy—on circulating tumor cells (CTCs) in men with localized prostate cancer. This prospective study, which enrolled subjects with biopsy-positive MRI-visible lesions (PIRADS ≥3), represents a critical step in understanding how surgical disruption of prostate tissue may influence cancer cell dissemination. By meticulously analyzing blood samples collected before, during, and after the procedure, Dr. Lau’s work provides foundational insights into the safety and systemic effects of this emerging technology. Her research bridges the gap between symptom relief and oncologic vigilance, offering a nuanced perspective that is invaluable for clinicians and researchers alike. Dr. Lau’s dedication to evidence-based innovation continues to shape the future of prostate cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Waterjet Resection for Men With Prostate Cancer Suffering From Lower Urinary Tract Symptoms
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago